Global Xerosis Treatment Market Size to Grow at a Steady Rate During Forecast Period 2026

Global Xerosis Treatment Market By Signs and Symptoms (Tightness, Roughness, Itching, Others), Medication (Corticosteroids, Immuno-Modulators, Topical Moisturizers, Others), Route of Administration (Oral, Topical, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Xerosis Treatment Market

Global xerosis treatment market is rising gradually with the substantial CAGR of 6.0% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of skin dryness may drive the market in the forecast period.

Market Definition: Global Xerosis Treatment Market

Xerosis or “dry skin” is caused by lack of moisture in the skin. This lack of moisture in skin can be caused by ageing or by underlying diseases such as diabetes. Xerosis generally occurs on the lower legs and can also occur on trunk, forearms and hands. It may appear on face too. Xerosis is also called xeroderma or xerosis cutis.

The prevalence of xerosis or xeroderma is approximately 1 case in 100,000 people. The occurrence of this condition in males and females is equal. The prevalence is more common in areas including North Africa and Middle East.

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-xerosis-treatment-market

Market Drivers

• Rising awareness about xerosis and its treatments will increase the market in the forecast period
• Influence of healthy and quality lifestyle and fashion industry are key factors that propel the market growth
• Increasing climatic changes and pollution are major causes of xerosis; which boosts the growth of the market
• Growing geriatric population will drive the market growth in the future

Market Restraints

• Presence of ineffective or fake products hampers the market growth
• Pressure of cost reduction of many potential products due to cut throat competition hinder the growth of the market
• Large number of low quality players which have fragmented the market may restraint the market growth

Segmentation: Global Xerosis Treatment Market

By Signs and Symptoms

• Tightness
• Roughness
• Itching
• Others

By Medication

• Corticosteroids
• Immuno-Modulators
• Topical Moisturizers
• Others

By Route of Administration

• Oral
• Topical
• Others

By End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

By Distribution Channels

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Others

By Geography

• North America
  • U.S.
  • Canada
  • Mexico
• South America
  • Brazil
  • Rest of South America
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific
• Middle East & Africa
  • South Africa
  • Rest of Middle East & Africa

Key Development in the Market:

• In April 2019, HRA Pharma announced an acquisition of Mederma, a skin care treatment product of Merz Pharma. Mederma is used for the treatment of scars, stretch marks and dry skin which is the most common symptom of xerosis. This acquisition will provide the rights to market and commercialize of the product worldwide which will strengthen the business portfolio of the company

Competitive Analysis:

Global xerosis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of xerosis treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in global xerosis treatment market are HRA Pharma, Merz Pharma, PuraCap Pharmaceutical LLC, Prince Care Pharma Pvt Ltd., Nemus Pharma, UAS Pharmaceuticals, Ovelle, CHEIRON PHARMA, Ceragenix Pharmaceuticals, Taro Pharmaceutical Industries Ltd., Galderma Laboratories, L.P., Unilever, Hempz, New Avon Company, Johnson & Johnson Services, Inc., Croda International Plc, Estée Lauder Inc, Dow, Pfizer Inc., Amgen Inc., Bayer AG, Mylan N.V. among others.